The Supply Test: Record Issuance Meets a Market in Structural Flux

The Supply Test Begins

The first half of 2026 rewrote the equity issuance record books. U.S. markets absorbed $307.7 billion in new equity across IPOs, follow-ons, and convertibles — a staggering total driven by a handful of mega-deals that dwarfed anything in the post-2021 era^[1]. Of that, roughly $155.8 billion came from 194 IPOs priced through July 2, with SpaceX alone accounting for $86.2 billion^[2].

Strip out SpaceX and the IPO market still printed $69.9 billion year-to-date — more than double the $31.6 billion raised in the same period of 2025^[2]. Follow-on offerings accounted for 60.5% of all H1 deals, making secondary supply, not fresh listings, the dominant plumbing event^[1].

The question entering the second half is no longer whether issuance is accelerating — it is whether the market’s demand machinery can absorb what comes next. My read: the math works for 2026 with roughly 65/35 odds, but tightens materially heading into 2027.

The SpaceX Lockup Clock

SpaceX priced its IPO at $135 on June 11 and began trading June 12, opening near $150 and briefly touching $225.64 in mid-June^[3]. Less than 5% of total shares were released into the public float at launch. Rather than a standard 180-day lockup, SpaceX adopted a staggered release schedule: tranches of roughly 7% unlock at days 70, 90, 105, 120, and 135 after the IPO^[3].

The first major wave hits shortly after the company reports Q2 earnings — expected in late July or early August — unlocking between 20% and 30% of total shares. That tranche alone releases roughly 911.5 million shares, valued at approximately $123 billion at recent prices^[3]. By the full 180-day mark on December 8, roughly 40% of all SpaceX shares will be freely tradable. Elon Musk’s personal holdings carry a 366-day lockup, meaning he cannot sell until approximately June 2027^[3].

The stock has already slipped below its IPO price, trading in the $124–$135 range as of mid-July^[3]. An ECM banker quoted by ION Analytics put it bluntly: “If SpaceX starts to trade down, that could close the door for other AI issuers”^[2].

The Buyback-to-Capex Pivot

For the better part of two decades, corporate buybacks functioned as the market’s structural bid — a relentless floor under equity prices. That mechanism is shifting, though not disappearing.

Goldman Sachs Research expects buybacks to exceed $1 trillion in 2026, which means corporate demand for shares should still outweigh corporate supply^[4]. Total issuance of roughly $700 billion (IPOs plus follow-ons) scales to about 1% of the equity market — actually below the long-term average^[4].

But the composition is changing. Tech hyperscaler repurchase activity is down 64% year-over-year, and aggregate S&P 500 buybacks as a percentage of market cap have slid to their lowest level since late 2023^[5]. Global buyback announcements, tracked across more than 11,000 firms, are close to their weakest nominal amount since before the pandemic^[5]. Capital is being redirected toward AI capex, R&D, and debt issuance — Alphabet raised $50 billion in a roughly two-day debt market window^[2] — at the direct expense of share repurchases.

The implication: the corporate bid that has historically absorbed new issuance may be thinner and more sector-selective than in past cycles. Goldman’s Ben Snider acknowledged that the math gets harder in 2027, as IPO floats expand, lock-ups expire, and more supply enters a market where buyback growth has already decelerated^[4].

The Anthropic–OpenAI Pipeline

Behind SpaceX, the IPO pipeline is dominated by two names that have confidentially filed: Anthropic and OpenAI^[2]. OpenAI may delay its listing until 2027, but Anthropic is widely expected to move first, potentially pricing in September or October^[2].

One US-based ECM banker noted that “Google came and raised $50 billion in roughly a two-day market,” suggesting enough capital exists to support both deals if sentiment holds^[2]. But a US investor quoted by ECM Pulse raised a structural concern: “Those companies don’t have the idiosyncratic features that the SpaceX setup had… I think that sounds terrible for the broader market if you have OpenAI and Anthropic both list in September and October”^[2].

The vulnerability is sentiment. Skepticism toward large language model providers is growing, even from voices previously counted among the technology’s strongest supporters^[2]. If the AI narrative frays, the IPO window could narrow quickly — and with it, the supply of new equity that has defined 2026.

Structural Transformation: The Plumbing Has Changed

Scott Rubner’s semiannual Market Structure & Flows review at Citadel Securities argues that the defining story of 2026 is not a macro event but the structural transformation of equity markets themselves^[6]. Five forces — concentration, passive dominance, retail participation, leverage, and volatility — are no longer independent trends; together, they increasingly determine how capital flows and prices are discovered.

The data points that matter for the supply-absorption question:

The optimistic read: $1.2 trillion in passive inflows and record retail participation create a deep, persistent bid that can absorb new supply — particularly when new listings index quickly and force mechanical buying. The cautious read: that same bid is increasingly concentrated in the same handful of names and sectors, leverage funding is tightening, and implied correlations are at multi-decade lows, meaning a single-name disappointment in a major IPO can cascade without a broader market buffer.

Europe Tells the Cautionary Tale

While U.S. markets celebrate, European listings continue to flounder. The IPO Health Index for EMEA remains near its post-2021 nadir, and the postponement of Franco-German tank maker KNDS — the most high-profile European IPO expected before the summer break — underscored the structural gap^[2].

European IPOs rely on a smaller, more selective investor base that demands discounts of at least 30% to peers, and sellers have been reluctant to accept those discounts^[2]. The contrast with the U.S. is instructive: SpaceX could rely on legions of retail investors and institutional FOMO to push the deal across the line, while European issuers face a buyer’s market where investors feel no obligation to participate^[2].

If U.S. sentiment shifts — whether triggered by a SpaceX lockup selloff, an AI earnings disappointment, or a macro surprise — the U.S. market could find itself closer to the European model faster than most expect.

What to Watch Next

1. SpaceX Q2 earnings (late July / early August): The first major lockup tranche unlocks within days of the print. If the stock is already below its $135 IPO price, the combination of earnings digestion and a 20–30% float expansion is a stress test for the entire AI-issuance narrative^[3].

2. Anthropic IPO pricing (September–October): The first pure LLM company to go public will reveal whether investor appetite for AI extends beyond infrastructure plays. A weak reception could narrow the window for OpenAI and the broader pipeline^[2].

3. Buyback announcements during Q2 earnings season: If the deceleration in repurchase announcements accelerates — particularly among hyperscalers — the corporate bid that has historically absorbed new issuance will be visibly thinner heading into 2027^[5].

4. Equity financing spreads and leverage ETF flows: Spreads at 138bps above SOFR signal tightening funding conditions^[6]. If leveraged ETF asset growth stalls or reverses, the mechanical amplification that has supported tech leadership could wobble.

5. Implied correlation regime: With 3-month correlations at 15-year lows^[6], the market is rewarding single-name selection. A regime shift back toward correlated moves — typically triggered by a macro shock — would simultaneously compress the dispersion trade and reduce the market’s capacity to absorb idiosyncratic IPO supply.

The Bottom Line

The 2026 issuance wave is real, record-breaking, and structurally significant. For now, the demand side — passive flows, retail participation, and a still-substantial buyback bid — is large enough to absorb it. My estimate: the market clears in 2026 with roughly 65/35 odds, with the 35% case involving a SpaceX-driven sentiment pullback that cascades into the Anthropic pricing window.

The harder question is 2027. As lock-ups expire, floats expand, buyback growth decelerates, and leverage funding tightens, the absorption math deteriorates. The market that priced SpaceX at $135 and Alphabet’s $50 billion debt deal in two days may not be the same market that faces $123 billion in newly tradable SpaceX shares while simultaneously digesting Anthropic and OpenAI listings. The structural transformation Rubner describes means the old playbook — buybacks as a floor, passive as a relentless bid, leverage as an amplifier — still works, but with diminishing margin for error.

Watch the lockup calendar. Watch the buyback announcements. And watch the financing spreads. The supply test is just beginning.